How a specific immune cytokine affects fat metabolism in the intestines
Official title: Regulation of intestinal lipid metabolism by type-3 immune cytokine
Funded at University of California Los Angeles · NIH-11055212 · Data updated 2026-11-12
This study is looking at how a specific immune protein helps your intestines handle fats, with the hope of finding new ways to treat obesity and related health issues that come from how your body processes fat.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | January 1, 2025 |
| Project end | November 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $91,073 |
| NIH project number | 1K99DK138289-01A1 |
| Project ID | NIH-11055212 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals struggling with obesity or metabolic disorders related to fat absorption.
✕Less likely to help
Patients with metabolic conditions unrelated to fat metabolism may not receive direct benefits from this research.
What this research studies
This research investigates the role of a type-3 immune cytokine in regulating how the intestines process and absorb fats. By understanding the mechanisms involved, the study aims to uncover potential therapeutic targets for conditions related to fat metabolism and absorption. Patients may benefit from insights that could lead to new treatments for obesity and related metabolic disorders. The research will utilize advanced techniques in immunology and lipid metabolism to explore these interactions.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for obesity and metabolic disorders by improving our understanding of fat metabolism.
How similar studies have gone: Previous research has shown promising results in understanding immune responses and metabolism, suggesting that this approach could yield valuable insights.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Gao, Yajing — University of California Los Angeles
- Study coordinator: Gao, Yajing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.